Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models

Immune checkpoint blockade (ICB) is currently evaluated in patients with glioblastoma (GBM), based on encouraging clinical data in other cancers, and results from studies with the methylcholanthrene-induced GL261 mouse glioma. In this paper, we describe a novel model faithfully recapitulating some k...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Genoud, Vassilis, Marinari, Eliana, Nikolaev, Sergey I, Castle, John C., Bukur, Valesca, Dietrich, Pierre-Yves, Okada, Hideho, Walker, Paul R.
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2018
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6279422/
https://ncbi.nlm.nih.gov/pubmed/30524896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1501137
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars